These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31948918)

  • 1. A serological investigation and genotyping of Toxoplasma gondii among Iranian blood donors indicates threat to health of blood recipients.
    Hosseini SA; Golchin E; Sharif M; Sarvi S; Ahmadpour E; Rostamian A; Gholami S; Amouei A; Daryani A
    Transfus Apher Sci; 2020 Jun; 59(3):102723. PubMed ID: 31948918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence and molecular detection of Toxoplasma gondii in healthy blood donors in southwest Iran.
    Saki J; Foroutan M; Khodkar I; Khodadadi A; Nazari L
    Transfus Apher Sci; 2019 Feb; 58(1):79-82. PubMed ID: 30579749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence and risk factors of Toxoplasma gondii infection among healthy blood donors in south-east of Iran.
    Mahmoudvand H; Saedi Dezaki E; Soleimani S; Baneshi MR; Kheirandish F; Ezatpour B; Zia-Ali N
    Parasite Immunol; 2015 Jul; 37(7):362-7. PubMed ID: 25891186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence and molecular diagnosis of Toxoplasma gondii infection among blood donors in southern Iran.
    Sarkari B; Shafiei R; Zare M; Sohrabpour S; Kasraian L
    J Infect Dev Ctries; 2014 Apr; 8(4):543-7. PubMed ID: 24727522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of Anti-Toxoplasma Gondii Antibodies in Healthy Voluntary Blood Donors from Mashhad City, Iran.
    Zarean M; Shafiei R; Gholami M; Fata A; Rahmati Balaghaleh M; Kariminik A; Tehranian F; Hasani A; Akhavan A
    Arch Iran Med; 2017 Jul; 20(7):441-445. PubMed ID: 28745905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High occurrence of Toxoplasma gondii infection among blood donors in Ardabil Province as main focus of zoonotic visceral leishmaniosis, northwestern Iran.
    Asfaram S; Rezaei R; Fakhar M; Ghezelbash B; Nakhaei M; Hezarjaribi HZ; Mardani A; Teshnizi SH
    Ann Parasitol; 2021; 67(4):611-617. PubMed ID: 35247301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence and molecular detection of Toxoplasma gondii among donors in a blood bank in Cúcuta, Colombia Introduction: Toxoplasma gondii infection.
    Ramírez AM; Ríos YK; Galvis NF; Entrena E; Mariño NV; Rangel DM; Araque MA; Cabarique DM; Murillo M; Gómez-Marín JE
    Biomedica; 2019 Aug; 39(Supl. 2):144-156. PubMed ID: 31529841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum IgG Anti-
    Nakashima F; Pardo VS; Miola MP; Murata FHA; Paduan N; Longo SM; Brandão de Mattos CC; Pereira-Chioccola VL; Ricci O; de Mattos LC
    Front Cell Infect Microbiol; 2019; 9():461. PubMed ID: 31993377
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of IgG and IgM anti-Toxoplasma gondii Antibodies in Blood Donors at Urmia Blood Transfusion Organization, Iran.
    Tappeh KH; Musavi J; Safa MB; Galavani H; Alizadeh H
    Turkiye Parazitol Derg; 2017 Mar; 41(1):1-4. PubMed ID: 28483726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genotyping and serological evaluation of Toxoplasma gondii in mothers and their spontaneous aborted fetuses in Southwest of Iran.
    Arefkhah N; Pourabbas B; Asgari Q; Moshfe A; Mikaeili F; Nikbakht G; Sarkari B
    Comp Immunol Microbiol Infect Dis; 2019 Oct; 66():101342. PubMed ID: 31437675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence and Associated Risk Factors for Toxoplasma gondii Infection in Healthy Blood Donors: A Cross-Sectional Study in Sonora, Mexico.
    Alvarado-Esquivel C; Rascón-Careaga A; Hernández-Tinoco J; Corella-Madueño MA; Sánchez-Anguiano LF; Aldana-Madrid ML; Velasquez-Vega E; Quizán-Plata T; Navarro-Henze JL; Badell-Luzardo JA; Gastélum-Cano JM; Liesenfeld O
    Biomed Res Int; 2016; 2016():9597276. PubMed ID: 27446960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic characterization of
    Hosseini SA; Sharif M; Sarvi S; Abediankenari S; Hashemi-Soteh MB; Amouei A; Montazeri M; Aghayan SA; Gholami S; Shaker D; Mizani A; Shabanzadeh S; Daryani A
    Parasitology; 2020 Mar; 147(3):322-328. PubMed ID: 31727203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence and genotypic analysis of Toxoplasma gondii from individuals in Scotland, 2006-2012.
    Burrells A; Opsteegh M; Pollock KG; Alexander CL; Chatterton J; Evans R; Walker R; McKenzie CA; Hill D; Innes EA; Katzer F
    Parasit Vectors; 2016 Jun; 9(1):324. PubMed ID: 27267112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence and genetic characterization of Toxoplasma gondii in cancer patients in Anhui Province, Eastern China.
    Wang L; He LY; Meng DD; Chen ZW; Wen H; Fang GS; Luo QL; Huang KQ; Shen JL
    Parasit Vectors; 2015 Mar; 8():162. PubMed ID: 25889184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and multilocus genotyping of Toxoplasma gondii isolates from congenital infection in north of Iran.
    Hosseini SA; Sharif M; Sarvi S; Mirzaei N; Abediankenari S; Arefkhah N; Amouei A; Gholami S; Anvari D; Ahmadpour E; Javidnia J; Jafar-Ramaji T; Daryani A
    Parasitol Res; 2023 Jan; 122(1):177-184. PubMed ID: 36369362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of
    Sadooghian S; Mahmoudvand H; Mohammadi MA; Nazari Sarcheshmeh N; Tavakoli Kareshk A; Kamiabi H; Zia-Ali N
    Iran J Parasitol; 2017; 12(4):554-562. PubMed ID: 29317880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence and molecular detection of Toxoplasma gondii in young healthy blood donors in Northern Iran.
    Kalantari N; Sheikhansari MR; Ghaffari S; Alipour J; Gorgani-Firouzjaee T; Tamadoni A; Bayani M
    Trop Biomed; 2018 Dec; 35(4):1017-1027. PubMed ID: 33601849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sero-molecular detection, multi-locus genotyping, and clinical manifestations of ocular toxoplasmosis in patients in northwest Iran.
    Arshadi M; Akhlaghi L; Meamar AR; Alizadeh Ghavidel L; Nasiri K; Mahami-Oskouei M; Mousavi F; Rampisheh Z; Khanmohammadi M; Razmjou E
    Trans R Soc Trop Med Hyg; 2019 Apr; 113(4):195-202. PubMed ID: 30624725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of anti-Toxoplasma IgG and IgM among individuals who were referred to medical laboratories in Mazandaran province, northern Iran.
    Sharif M; Daryani A; Ebrahimnejad Z; Gholami S; Ahmadpour E; Borhani S; Lamsechi N
    J Infect Public Health; 2016; 9(1):75-80. PubMed ID: 26159578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of anti-toxoplasma Gondii antibodies in Turkish blood donors.
    Yazar S; Eser B; Yay M
    Ethiop Med J; 2006 Jul; 44(3):257-61. PubMed ID: 17447392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.